Impaired sleep and rhythms in persons with cancer

Sleep Medicine Reviews

Volumn 8, Issue 3, 2004, Pages 199-212

  Lee, Kathryn ^a   Cho, Maria ^a   Miaskowski, Christine ^a   Dodd, Marylin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bone marrow transplant; Breast cancer; Colorectal cancer; Fatigue; Gynecological cancer; Hematological cancer; Insomnia; Lung cancer; Prostate cancer; Sleep

Indexed keywords

ANTINEOPLASTIC AGENT; HORMONE; HYPNOTIC SEDATIVE AGENT; TAMOXIFEN;

ACTIMETRY; ADVANCED CANCER; ANAMNESIS; BEHAVIOR; BLADDER IRRITATION; BONE MARROW TRANSPLANTATION; BREAST CARCINOMA; CANCER HORMONE THERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER THERAPY; CAREGIVER; CIRCADIAN RHYTHM; CIRCADIAN RHYTHM SLEEP DISORDER; CLINICAL PROTOCOL; COGNITIVE THERAPY; COLON CARCINOMA; COMPARATIVE STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; FUNCTIONAL ASSESSMENT; GASTROINTESTINAL CARCINOMA; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HEMATOLOGIC MALIGNANCY; HOT FLUSH; HUMAN; IMMUNE SYSTEM; LUNG CARCINOMA; MEDICAL RESEARCH; MELANOMA; PATIENT EDUCATION; PREVALENCE; PROSTATE CARCINOMA; QUALITY OF LIFE; REVIEW; SELF REPORT; SEX DIFFERENCE; SLEEP DISORDER; SLEEP PATTERN; SLEEP TIME; SLEEP WAKING CYCLE; SOMNOLENCE; SURGICAL TECHNIQUE; TREATMENT OUTCOME; URINARY FREQUENCY; WELLBEING;

EID: 2642516341     PISSN: 10870792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smrv.2003.10.001     Document Type: Article

References (89)

1. American Cancer Society, www.cancer.org
2. Ancoli-Israel S, Moore PJ, Jones V. The relationship between fatigue and sleep in cancer patients: a review. Eur J Cancer Care 2001; 10: 245-255.
3. Davidson JR, MacLean AW, Brundage MD, Schulze K. Sleep disturbance in cancer patients. Soc Sci Med 2002; 54: 1309-1321.
4. Savard J, Morin CM. Insomnia in the context of cancer: a review of a neglected problem. J Clin Onc 2001; 19: 895-908.
5. National Sleep Foundation, www.sleepfoundation.org.
6. Grond S, Zech D, Diefenbach C, Bischoff A. Prevalence and pattern of symptoms in patients with cancer pain: a prospective evaluation of 1635 cancer patients referred to a pain clinic. J Pain Symptom Manage 1994; 9: 372-382.
7. Savard J, Simard S, Blanchet J, Ivers H, Morin CM. Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer. Sleep 2001; 24: 583-590.
8. Redeker NS, Lev EL, Ruggiero J. Insomnia, fatigue, anxiety, depression, and quality of life of cancer patients undergoing chemotherapy. Sch Inq Nurs Pract 2000; 14: 275-290.
9. Brandberg Y, Mansson-Brahme E, Ringborg U, Sjoden PO. Psychological reactions in patients with malignant melanoma. Eur J Cancer 1995; 2: 157-162.
10. Knobf MT. Physical and psychologic distress associated with adjuvant chemotherapy in women with breast cancer. J Clin Oncol 1986; 4: 678-684.
11. Omne-Ponten M, Holmberg L, Burns T, Adami HO, Bergstrom R. Determinants of the psycho-social outcome after operation for breast cancer. Results of a prospective comparative interview study following mastectomy and breast conservation. Eur J Cancer 1992; 28A: 1062-1067.
12. Woo B, Dibble SL, Piper BF, Keating SB, Weiss MC. Differences in fatigue by treatment methods in women with breast cancer. Oncol Nurs Forum 1998; 25: 915-920.
13. Greenberg DB, Sawicka J, Eisenthal S, Ross D. Fatigue syndrome due to localized radiation. J Pain Symptom Manage 1992; 7: 38-45.
14. Berger AM, Farr L. The influence of daytime inactivity and nighttime restlessness on cancer-related fatigue. ONF 1999; 26: 1663-1671.
15. Andrykowski MA, Curran SL, Lightner R. Off-treatment fatigue in breast cancer survivors: a controlled comparison. J Behav Med 1998; 21: 1-18.
16. Fortner BV, Stepanski EJ, Wang SC, Kasprowicz S, Durrence H. Sleep and quality of life in breast cancer patients. J Pain Symptom Manage 2002; 24: 471-480.
17. Bower JE, Ganz PA, Desmond YA, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 2000; 18: 743-753.
18. Carpenter JS, Andrykowski MA. Menopausal symptoms in breast cancer survivors. ONF 1999; 26: 1311-1317.
19. Broeckel JA, Jacobsen PB, Horton J, Balducci L, Lyman GH. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol 1998; 16: 1689-1696.
20. Stein KD, Jacobsen PB, Hann DM et al. Impact of hot flashes on quality of life among postmenopausal women being treated for breast cancer. J Pain Symptom Manage 2000; 19: 436-445.
21. Berger AM, Higgenbotham P. Correlates of fatigue during and following adjuvant breast cancer chemotherapy: a pilot study. ONF 2000; 27: 1443-1448.
22. Love RR, Cameron L, Connell BL, Leventhal H. Symptoms associated with tamoxifen treatment in postmenopausal women. Arch Intern Med 1991; 151: 1842-1847.
23. Senie RT, Rosen PP, Rhodes P, Lesser ML. Timing of breast cancer excision during the menstrual cycle influences duration of disease-free survival. Ann Intern Med 1991; 115: 337-342.
24. Badwe RA, Gregor WM, Chaudary MA, Richards MA et al. Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer. Lancet 1991; 337: 1261-1264.
25. Christman NJ, Oakley MG, Cronin SN. Developing and using preparatory information for women undergoing radiation therapy for cervical or uterine cancer. ONF 2001; 28: 93-98.
26. Nail LM. Coping with intracavitary radiation treatment for gynecologic cancer. Cancer Pract 1993; 1: 218-224.
27. Savard J, Miller SM, Mills M, O'Leary A, Harding H et al. Association between subjective sleep quality and depression on immunocompetence in low-income women at risk for cervical cancer. Psychosom Med 1999; 61: 496-507.
28. Irwin M, Smith TL, Gillin JC. Electroencephalographic sleep and natural killer activity in depressed patients and control subjects. Psychosom Med 1992; 54: 10-21.
29. Greenberg DB, Gray JL, Mannix CM, Eisenthal S, Carey M. Treatment-related fatigue and serum interleukin-1 levels in patients during external beam irradiation for prostate cancer. J Pain Symptom Manage 1993; 8: 196-200.
30. Krueger JM, Karnovsky ML. Sleep as a neuroimmune phenomenon: a brief historical perspective. Adv Neuroimmunol 1995; 5: 5-12.
31. Lee KA, Miaskowski C, West C, Dodd M, Elder M, Paul S, Wara W. Changes in sleep and fatigue during radiation for prostate cancer. Sleep 2003; 26(1).
32. Ginsburg ML, Quirt C, Ginsburg AD, MacKillop WJ. Psychiatric illness and psychosocial concerns of patients with newly diagnosed lung cancer. CMAJ 1995; 152: 701-708.
33. Sarna L. Correlates of symptom distress in women with lung cancer. Cancer Pract 1993; 1: 21-28.
34. Silberfarb PM, Hauri PJ, Oxman TE, Schnurr P. Assessment of sleep in patients with lung cancer and breast cancer. J Clin Oncol 1993; 11: 997-1004.
35. Portenoy RK, Thaler HT, Kornblith AB et al. Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res 1994; 3: 183-189.
36. Nordin K, Glimelius B. Predicting delayed anxiety and depression in patients with gastrointestinal cancer. Br J Cancer 1999; 79: 525-529.
37. Faithfull S. Patients' experiences following cranial radiotherapy: a study of the somnolence syndrome. J Adv Nurs 1991; 16: 939-946.
38. Harrison LB, Zelefsky MJ, Pfister DG, Carper E, Raben A et al. Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue. Head and Neck 1997; 19: 169-175.
39. Munro AJ, Potter S. A quantitative approach to the distress caused by symptoms in patients treated with radical radiotherapy. Br J Cancer 1996; 74: 640-647.
40. Molassiotis A. A correlational evaluation of tiredness and lack of energy in survivors of haematological malignancies. Eur J Cancer Care 1999; 8: 19-25.
41. Wang XH, Giralt SA, Mendoza TR, Engstrom MC et al. Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin's lymphoma. J Clin Oncol 2002; 20: 1319-1328.
42. Smets EMA, Visser MRM, Willems-Groot AFMN, Garssen B et al. Fatigue and radiotherapy: (A) experience in patients undergoing treatment. Br J Cancer 1998; 78: 899-906.
43. Smets EMA, Visser MRM, Willems-Groot AFMN et al. Fatigue and radiotherapy: (B) experience in patients 9 months following treatment. Br J Cancer 1998; 78: 907-912.
44. Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 2002; 59: 131-136.
45. Lawrence CC, Gilbert CJ, Peters WP. Evaluation of symptom distress in a bone marrow transplant outpatient environment. Ann Pharmacother 1996; 30: 941-945.
46. Andrykowski MA, Carpenter JS, Greiner CB et al. Energy level and sleep quality following bone marrow transplantation. Bone Marrow Transplant 1997; 20: 669-679.
47. Longman AJ, Braden CJ, Mishell MH. Side-effects burden, psychological adjustment, and life quality in women with breast cancer: pattern of association over time. ONF 1999; 26: 909-915.
48. Krech RL, Walsh D. Symptoms of pancreatic Cancer. J Pain Symptom Manage 1991; 6: 360-367.
49. Okuyama T, Tanaka K, Akechi T, Kugaya A et al. Fatigue in ambulatory patients with advanced lung cancer: prevalence, correlated factors, and screening. J Pain Symptom Manage 2001; 22: 554-564.
50. Geels P, Eisenhauer E, Bezjak A, Zee B, Day A. Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastic breast cancer. J Clin Oncol 2000; 12: 2396-2405.
51. Miaskowski C, Lee KA. Pain, fatigue, and sleep disturbances in oncology outpatients receiving radiation therapy for bone metastasis: a pilot study. J Pain Symptom Manage 1999; 17: 320-332.
52. Lewin DS, Dahl RE. Importance of sleep in the management of pediatric pain. J Dev Behav Pediatr 1999; 20: 244-252.
53. Hockenberry-Eaton M, Hinds PS, Alcoser P, O'Neill JB et al. Fatigue in children and adolescents with cancer. J Ped Oncol Nurs 1998; 15: 172-182.
54. Wilcox S, King A. Sleep complaints in older women who are family caregivers. J Gerontol: Psychol Sci 1999; 54B: P189-P198.
55. Picot SJF, Zauszniewski JA, Debanne SM, Holston EC. Mood and blood pressure responses in black female caregivers and noncaregivers. Nurs Res 1999; 48: 150-161.
56. Carter PA, Chang BL. Sleep and depression in cancer caregivers. Cancer Nurs 2000; 23: 410-415.
57. Given BA, Given CW, Kozachik S. Family support in advanced cancer. CAA Cancer J Clin 2001; 51: 213-231.
58. Ferrell BR, Rhiner M, Shapiro B, Dierkes M. The experience of pediatric cancer pain. Part I: impact of pain on the family. J Ped Nurs 1994; 9: 368-379.
59. Scheving LE, Burns ER, Pauly JE, Halberg F, Haus E. Survival and cure of leukemic mice after circadian optimization of treatment with cyclophosphamide and 1-B-D-arabinofuranosylcytosine. Cancer Res 1977; 37: 3648-3655.
60. Hrushesky WJ. Circadian timing of cancer chemotherapy. Science 1985; 5: 73-75.
61. Levi F, Misset J, Brienza S, Adam R, Metzger G et al. A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. Cancer 1992; 69: 893-900.
62. Levi FA, Zidani R, Vannetzel J, Perpoint B, Focan C et al. Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial. J Natl Cancer Inst 1994; 86: 1608-1617.
63. Levi F, Zidani R, Misset J. Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. Lancet 1997; 350: 681-686.
64. Sato S, Irie T, Kanamori Y, Akeshima R. Timing of G-CSF administration based on the circadian rhythm in patients with ovarian cancer. Am J Clin Oncol 2002; 25: 289-290.
65. Metzger G, Massari C, Etienne M-C, Comisso M et al. Spontaneous or imposed circadian changes in plasma concentrations of 5-fluorouracil coadministered with folinic acid and oxaliplatin: relationship with mucosal toxicity in patients with cancer. Clin Pharmacol Ther 1994; 56: 190-201.
66. Mormont MC, Levi F. Circadian-system alterations during cancer processes: a review. Int J Cancer 1997; 70: 241-247.
67. Mormont MC, De Prins J, Levi F. Assessment of activity rhythms of wrist actigraphy: preliminary results in 30 patients with colorectal cancer. Pathol Biol 1996; 44: 165-171.
68. Mormont MC, Waterhouse J. Contribution of the rest-activity circadian rhythm to quality of life in cancer patients. Chronobiol Int 2002; 19: 313-323.
69. Mormont MC, Waterhouse JM, Bleuzen P, Giacchetti S et al. Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res 2000; 6: 3038-3045.
70. Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst 2000; 92: 994-1000.
71. Stiefel FC, Kornblith AB, Holland JC. Changes in the prescription patterns of psychotropic drugs for cancer patients during a 10-year period. Cancer 1990; 65: 1048-1053.
72. Derogatis LR, Feldstein M, Morrow G, Schmale A et al. A survey of psychotropic drug prescriptions in an oncology population. Cancer 1979; 44: 1919-1929.
73. Engstrom CA, Strohl RA, Rose L et al. Sleep alterations in cancer patients. Cancer Nurs 1999; 22: 143-148.
74. Love RR, Leventhal H, Easterline DV, Nerenz DR. Side effects and emotional distress during cancer chemotherapy. Cancer 1989; 63: 604-612.
75. Vogelzang NJ, Breitbart W, Cella D, Curt GA et al. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment study. Semin Hematol 1997; 34(2): 4-12.
76. Cover H, Irwin M. Immunity and depression: insomnia, retardation, and reduction of natural killer cell activity. J Behav Med 1994; 17: 217-223.
77. Vgontzas AN, Papanicolaou DA, Bixler EO, Lotsikas A et al. Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab 1999; 84: 2603-2607.
78. Alapin I, Fichten CS, Libman E, Creti L et al. How is good and poor sleep in older adults and college students related to daytime sleepiness, fatigue, and ability to concentrate? J Psychosom Res 2000; 49: 381-390.
79. Richardson A, Ream EK. Self-care behaviours initiated by chemotherapy patients in response to fatigue. Int J Nurs Stud 1997; 34: 35-43.
80. Morin CM, Culbert JP, Schwartz SM. Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry 1994; 151: 1172-1180.
81. Murtaugh DR, Greenwood KM. Identifying effective psychological treatments for insomnia: a meta-analysis. J Consult Clin Psychol 1995; 63: 79-89.
82. Davidson JR, Waisberg JL, Brundage MD, MacLean AW. Nonpharmacologic group treatment of insomnia: a preliminary study with cancer survivors. Psycho-Oncology 2001; 10: 389-397.
83. Cannici J, Malcolm R, Peek LA. Treatment of insomnia in cancer patients using muscle relaxation training. J Behav Ther Exp Psychiatry 1983; 14: 251-256.
84. Lee KA. Sleep and fatigue. Annu Rev Nurs Res 2000; 19: 249-273.
85. Segar ML, Katch VL, Roth RS, Garcia AW et al. The effect of aerobic exercise on self-esteem and depressive and anxiety symptoms among breast cancer survivors. Oncol Nurs Forum 1998; 25: 107-113.
86. Mock V, Hassey Dow K, Meares CJ et al. Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer. ONF 1997; 24: 991-1000.
87. Dimeo F, Bertz H, Finke J. An aerobic exercise programme for patients with haematological malignancies after bone marrow transplantation. Bone Marrow Transplant 1996; 18: 1157-1160.
88. Dimeo FC, Stieglitz RD, Novelli-Fischer U, Fetscher S, Keul J. Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy. Cancer 1999; 85: 2273-2277.
89. Spielman AJ, Glovinsky PB. The varied nature of insomnia. In P Hauri (Ed). Case studies in insomnia. New York: Plenum Press, 1991, pp.1-15.